The Public Health Agency of Canada has already begun using the Pfizer-BioNTech vaccine to immunize people against COVID-19, and thousands of doses of Moderna are expected to arrive in Canada a matter ...
Alan Bernstein, who is a member of Canada’s Vaccine Task Force, the group that advised the government as to which vaccines to buy, says these first two options use a similar technology and are fairly ...
Children as young as 6 months can now receive a COVID-19 vaccine to protect them against severe disease, hospitalization and death. And they have two choices: One from Moderna and one from Pfizer and ...
Dr. Gustavo Ferrer, President of Aventura Pulmonary Institute, joins Yahoo Finance's Kristin Myers to discuss the latest coronavirus developments, as the FDA prepares to vote on emergency use of the ...
A Wednesday morning technical briefing held by the province explained the difference between the mRNA vaccines produced by Pfizer-BioNTech and Moderna and the viral vector vaccines made by AstraZeneca ...
Coronavirus news headlines on April 8: Under 30s to be offered alternative to AstraZeneca, Covid prevalence in England dropped & more More than 31 million people in the UK have received their first ...
Visit the Business section of Insider for more stories. Coronavirus vaccines are the world's escape route out of a pandemic. Each is given as a shot in the muscle of the upper arm. For the two-dose ...
As Canada approves more COVID-19 vaccines, health officials are advising to take the first one made available to you despite its efficacy rate. Experts say a vaccine’s effectiveness and efficacy are ...
The difference between a fall in which COVID-19 is in retreat and one where it surges back in a fourth deadly wave may come down to whether Canada can achieve a B or an A+ with its vaccination effort.
And then there were two. With Health Canada’s decision to approve a second COVID-19 vaccine — the American-developed Moderna — there will soon be two vaccine options in this country.
Soon, there could be two. Health Canada is expected to make a regulatory decision imminently on a second COVID-19 vaccine.